UK

Uday Kumar Karna

Active Director Director DIN 10086006
DIN 10086006 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Uday Kumar Karna

Data last updated:

Uday Kumar Karna is a Director at Soulcia Healthcare Private Limited (since 2023). Soulcia Healthcare Private Limited reported revenue of ₹4.3 Lakh (FY 2024).

DIN 10086006
Primary Designation Director
First Appointment 23 Mar 2023
Oldest Company Age 3 yrs
Largest company Soulcia Healthcare Private Limited · ₹4.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Soulcia Healthcare Private Limited U47721DL2023PTC411507
Director23 Mar 20232023₹4.3 Lakh (FY 2024)Active

Board colleagues of Uday Kumar Karna

NameDINCompanyDesignation
Sughosh Narayan10086005Soulcia Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Soulcia Healthcare Private Limited
Premium access

Shareholding and investment profile for Uday Kumar Karna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uday Kumar Karna

Uday Kumar Karna currently holds 1 directorship: Soulcia Healthcare Private Limited (Director, since 23 Mar 2023, revenue ₹4.3 Lakh (FY 2024)).

Uday Kumar Karna was first appointed on 23 Mar 2023 as Director at Soulcia Healthcare Private Limited.

The current boards of Uday Kumar Karna's companies include Sughosh Narayan (Soulcia Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available